We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Neuroleptic Withdrawal in Schizophrenic Patients

Ross J. Baldessarini, MD; Adele C. Viguera, MD; Gianni L. Faedda, MD; David L. Garver, MD; Trisha Suppes, MD, PhD; Leonardo Tondo, MD; Daniel van Kammen, MD, PhD; Richard J. Wyatt, MD; David M. Gardner
Arch Gen Psychiatry. 1995;52(3):189-192. doi:10.1001/archpsyc.1995.03950150021002.
Text Size: A A A
Published online


IN THIS issue of the Archives, Gilbert and her colleagues1 provide a scholarly, comprehensive meta-analysis of research concerning the discontinuation of neuroleptic treatment. We find that additional information can be obtained from their analyses, which adds to an emerging impression that abrupt withdrawal of neuroleptic drugs and other maintenance medications is associated with a high risk for early recurrence of acute illness. Their analysis involves a total of nearly 5600 psychotic patientsubjects in 66 studies reported between 1958 and 1993, including 29 paired comparisons with cohorts continued on treatment with medication. The results strongly indicate that the discontinuation of maintenance neuroleptic medication carries a significant early risk for severe exacerbation of illness ("relapse"), averaging 53% within 9.7 months after discontinuation vs 15.6% with continued medication. These results accord closely with a similar analysis of this literature up to the early 1980s, in which the risk after stopping neuroleptic treatment


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.